| Identification | Back Directory | [Name]
Almoxatone | [CAS]
84145-89-1 | [Synonyms]
MD-240928
Almoxaton
Almoxatone
Almoxatonum
Unii-85V47mce4z
Almoxatone [inn]
( -)-(R)-3-(4-(2-Chlorbenzyloxy)phenyl)-5-((methylamino)methyl)-2-oxazolidinon
( )-(R)-3-(p-((m-Chlorobenzyl)oxy)phenyl)-5-((methylamino)methyl)-2-oxazolidinone
[5R,(+)]-3-[4-[(3-Chlorobenzyl)oxy]phenyl]-5-[(methylamino)methyl]-2-oxazolidinone
[5R,(+)]-3-[4-[(3-Chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]-2-oxazolidinone
2-Oxazolidinone, 3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]-, (5R)- | [Molecular Formula]
C18H19ClN2O3 | [MDL Number]
MFCD00865340 | [MOL File]
84145-89-1.mol | [Molecular Weight]
346.81 |
| Hazard Information | Back Directory | [Uses]
Almoxatone is an orally effective, long-acting inhibitor of MAO-B[1]. | [References]
[1] Keller HH, et al. Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):12-20. DOI:10.1007/BF00165029 |
|
|